Boscolo, Annalisa
Sella, Nicolò
Lorenzoni, Giulia
Pettenuzzo, Tommaso
Pasin, Laura
Pretto, Chiara
Tocco, Martina
Tamburini, Enrico
De Cassai, Alessandro
Rosi, Paolo
Polati, Enrico
Donadello, Katia
Gottin, Leonardo
De Rosa, Silvia
Baratto, Fabio
Toffoletto, Fabio
Ranieri, V. Marco
Gregori, Dario
Navalesi, Paolo https://orcid.org/0000-0002-3733-3453
,
Valeri, Ilaria
Andreatta, Giulio
Gandolfi, Leonardo
Gadaldi, Alessandra
Brumana, Nicolò
Forin, Edoardo
Correale, Christelle
Pesenti, Elisa
Fregolent, Davide
Pirelli, Pier Francesco
Marchesin, Davide
Perona, Matteo
Franchetti, Nicola
Della Paolera, Michele
Simoni, Caterina
Falcioni, Tatiana
Tresin, Alessandra
Schiavolin, Chiara
Schiavi, Aldo
Vathi, Sonila
Sartori, Daria
Sorgato, Alice
Pistollato, Elisa
Linassi, Federico
Serra, Eugenio
Pittarello, Demetrio
Tiberio, Ivo
Bond, Ottavia
Michieletto, Elisa
Muraro, Luisa
Peralta, Arianna
Persona, Paolo
Petranzan, Enrico
Zarantonello, Francesco
Graziano, Alessandro
Piasentini, Eleonora
Bernardi, Lorenzo
Pianon, Roberto
Badii, Flavio
Bosco, Enrico
Agostini, Moreno
Farnia, Antonio
Peta, Mario
Calò, Mauro Antonio
Meggiolaro, Marco
Lazzari, Francesco
Martinello, Ivan
Fullin, Giorgio
Papaccio, Francesco
Bonato, Alfeo
Sgarabotto, Camilla
Montacciani, Francesco
Alessandra, Parnigotto
Gagliardi, Giuseppe
Ferraro, Gioconda
Ongaro, Luigi
Baiocchi, Marco
Danzi, Vinicio
Zanatta, Paolo
Marchiotto, Simonetta
Bassanini, Silvia
Zamperini, Massimo
Daroui, Ivan
Funding for this research was provided by:
Regione del Veneto
Article History
Received: 6 April 2021
Accepted: 4 July 2021
First Online: 28 July 2021
Declarations
:
: The study was approved by the Institutional Ethical Committee of each participating center (coordinator center approval reference number 4853AO20, while the full list of all approval reference numbers is available in Additional file ).
: Written informed consent was obtained from each patient according to national regulation.
: None related to the present work. PN received royalties from Intersurgical for Helmet Next invention and speaking fees from Philips, Resmed, MSD, Drager and Novartis. The other authors have no other competing interests to declare.